Azitra, Inc. 8-K

What Happened
Azitra, Inc. (AZTR) announced a private investment in public equity (PIPE) transaction in a Securities Purchase Agreement signed March 18, 2026 and closed March 20, 2026. The company sold 10,485 shares of newly created Series A convertible non-redeemable preferred stock, each sold with two attached warrants (Series B and Series C), at $1,000 per packaged Security, raising initial gross proceeds of approximately $10.5 million. If all warrants are exercised for cash, the PIPE could generate up to approximately $31.4 million in additional gross proceeds.

Key Details

• Structure: 10,485 Series A preferred shares issued; each preferred includes a Series B Warrant and a Series C Warrant (each warrant initially exercisable for 8,128.1 common shares).
• Warrant economics: Exercise price of $0.123 per share; Series B terminates 18 months after required stockholder approval; Series C termination tied to timing of a public cosmetic filaggrin human study announcement (with limited reset/extension mechanics).
• Conversion & approvals: Series A preferred will not convert to common stock until shareholders approve an increase in authorized common shares and the issuance under NYSE American rules; automatic conversion (once approved) equals ~8,128.1 common shares per preferred (subject to adjustments and ownership limits).
• Investor protections/limits: Beneficial ownership limits (4.99%, 9.99% or 19.99%, elected by each purchaser) may restrict immediate exercises; purchasers may receive pre-funded warrants instead in some cases.
• Registration & remedies: Azitra agreed to file a resale registration statement within 45 days of closing and to use commercially reasonable efforts to get it effective; liquidated damages of 1.0% of a purchaser’s investment per 30-day period apply for certain registration delays.
• Participants & disclosure: Purchasers include the CEO, a company consultant, and a >5% stockholder. The company issued a press release on March 19, 2026 announcing the pricing.

Why It Matters
This financing provides Azitra with near-term cash (about $10.5M received at closing) and potential additional capital if warrants are exercised (up to ~$31.4M total). For shareholders, the filing signals possible future dilution: conversion of preferred stock and exercise of large warrant positions would increase the number of outstanding common shares significantly, though conversions/exercises are gated by shareholder approvals and ownership limits. The company also commits to registering the issued securities for resale, which could make the new shares more liquid for the PIPE investors once the registration is effective. Investors should note the key conditions (stockholder approval, registration timing, and beneficial ownership limits) that affect when and how much dilution could actually occur.